Atlas Trials

Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma

Clinical trial NCT04435977 · UNKNOWN

Trial details

NCT number
NCT04435977
Sponsor
Istituto Clinico Humanitas
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocarcinoma
Start date
2020-01-30
Primary completion
2023-06-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.